← Open Payments lookup

LUKE KOONG: Open Payments

NPI 1184250524 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,461 in 51 payments from 14 companies in 2025. Trend: 2023 $277 · 2024 $1,211 · 2025 $1,461

Food & beverage: $1,443Education: $19
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP13$541
Novo Nordisk Inc7$209
Boehringer Ingelheim Pharmaceuticals, Inc.11$204
Amgen Inc.2$137
Sumitomo Pharma America, Inc.5$85
Bayer Healthcare Pharmaceuticals Inc.3$61
GlaxoSmithKline, LLC.2$43
Exact Sciences Corporation2$41
Hologic Sales and Service, LLC1$35
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$24

Products named: BREZTRI, Ozempic, JARDIANCE, AIRSUPRA, REPATHA, FARXIGA, GEMTESA, Kerendia.

Industry payments across TX — which companies pay providers there.